A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
8
Participants
Timeline
Start Date
September 30, 2010
Primary Completion Date
October 31, 2010
Conditions
Healthy
Interventions
DRUG
BI 671800
High dose oral drinking solution
Trial Locations (1)
Unknown
1268.7.001 Boehringer Ingelheim Investigational Site, Madison
NCT01205373 - A Phase I Trial to Investigate the Metabolism and Pharmacokinetics as Well as Safety and Tolerability of a Single Dose BI671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter